Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment

por Kim, Richard, Chiorean, E Gabriela, Amin, Manik, Rocha-Lima, Caio Max S, Gandhi, Jitendra, Harris, William P, Song, Tao, Portnoy, David
Publicado 2017

Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung...

por Li, Chao, Hart, Lowell, Owonikoko, Taofeek K., Aljumaily, Raid, Rocha Lima, Caio Max, Conkling, Paul R., Webb, Roy Timothy, Jotte, Robert M., Schuster, Steven, Edenfield, William J., Smith, Deborah A., Sale, Mark, Roberts, Patrick J., Malik, Rajesh K., Sorrentino, Jessica A.
Publicado 2021